Arcturus Therapeutics Holdings (ARCT)
(Real Time Quote from BATS)
$25.68 USD
-1.30 (-4.82%)
Updated Apr 25, 2024 10:08 AM ET
3-Hold of 5 3
C Value A Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -1.17 |
EPS Last Quarter | -0.32 |
Last EPS Surprise | 81.07% |
ABR | 1.44 |
Earnings ESP
|
-5.43% |
---|---|
Current Year | -2.83 |
Next Year | 2.64 |
EPS (TTM) | -2.03 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 22.12M | 38.12M | 186.33M | 386.95M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 29.35M | 73.36M | 293.46M | 771.02M |
Low Estimate | 10.00M | 15.00M | 112.02M | 167.42M |
Year ago Sales | 80.29M | 10.52M | 169.93M | 186.33M |
Year over Year Growth Est. | -72.45% | 262.36% | 9.65% | 107.67% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.17 | -0.60 | -2.83 | 2.64 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -1.23 | -1.22 | -1.54 | 0.53 |
High Estimate | -0.84 | 0.22 | -0.48 | 9.92 |
Low Estimate | -1.43 | -1.22 | -5.97 | -2.53 |
Year ago EPS | 0.88 | -1.98 | -1.99 | -2.83 |
Year over Year Growth Est. | -232.95% | 69.70% | -42.21% | 193.20% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 2 | 2 | 1 |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 2 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.17 | -0.60 | -2.83 | 2.64 |
7 Days Ago | -0.79 | -0.29 | -1.42 | 5.10 |
30 Days Ago | -0.79 | -0.29 | -1.42 | 5.10 |
60 Days Ago | -0.60 | -0.59 | -1.71 | 11.79 |
90 Days Ago | -0.60 | -0.59 | -1.71 | 11.68 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.23 | -1.22 | -1.54 | 0.53 |
Zacks Consensus Estimate | -1.17 | -0.60 | -2.83 | 2.64 |
Earnings ESP | -5.43% | -103.33% | 45.54% | -79.92% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.32 | -0.61 | -1.98 | 0.88 | NA |
Estimate | -1.69 | -1.79 | 0.09 | 2.92 | NA |
Difference | 1.37 | 1.18 | -2.07 | -2.04 | -0.39 |
Surprise | 81.07% | 65.92% | -2,300.00% | -69.86% | -555.72% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more